Bio-decontamination Equipment Market Size, Share, Growth, and Industry Analysis, By Type (Vaporized Hydrogen Peroxide Sterilization,Gamma Irridation,Others), By Application (Pharmaceutical Manufacturing,Bioscience Research,Hospital and Healthcare), Regional Insights and Forecast to 2035

Bio-decontamination Equipment Market Overview

The global Bio-decontamination Equipment Market is forecast to expand from USD 414.67 million in 2026 to USD 436.65 million in 2027, and is expected to reach USD 660.02 million by 2035, growing at a CAGR of 5.3% over the forecast period.

The global Bio-decontamination Equipment Market Report shows equipment segment value at approximately USD 145.6 million in 2023, with room and chamber decontamination systems representing about 60% of equipment units worldwide. The market has grown annual unit shipments by roughly 11% in 2022–2023 in pharma manufacturing cleanrooms, and over 8,000 new units were installed across North America and Europe in 2023. The Bio-decontamination Equipment Market Size is hence driven by widespread demand for sterilization systems in regulated industries. Key clean-room manufacturers report system downtimes dropped by about 15% with automated decontamination equipment, demonstrating cost-savings and efficiency benefits. This underlines strong Bio-decontamination Equipment Market Growth prospects for equipment players globally.

In the USA, the Bio-decontamination Equipment Market Analysis highlights domestic equipment installations at roughly USD 93 million in 2023, representing about 64% of the global equipment-segment value of USD 145.6 million. US pharmaceutical and biotech clean-room sites added approximately 3,500 new decontamination machines in 2022–2023, while hospital and healthcare end-users adopted nearly 1,200 units in 2023, representing roughly 19% of US installations. US producers achieved service contract uptakes increasing by about 22% year-on-year in 2023. The US region thus represents a dominant portion of the Bio-decontamination Equipment Market Share and is central to Bio-decontamination Equipment Market Outlook for North America.

Get Comprehensive Insights into the Market’s Size and Growth Trends

Download FREE Sample

Key Findings

• Key Market Driver: 45% of global pharmaceutical sites adopted automated equipment for bio-decontamination in 2023.
• Major Market Restraint: 32% of emerging-market biopharma sites cite high equipment capital cost as a barrier.
• Emerging Trends: 28% of installations in 2023 used mobile decontamination systems for rapid room turnaround.
• Regional Leadership: North America held about 64% of equipment segment value in 2023.
• Competitive Landscape: Top three equipment players collectively held ~55% of global equipment unit shipments in 2023.
• Market Segmentation: Equipment sales accounted for ~52% of total bio-decontamination market by value in 2023.
• Recent Development: 19% of manufacturers expanded capacity in 2023 with new production lines and added roughly 10% to global capacity.

Bio-decontamination Equipment Market Latest Trends

In the Bio-decontamination Equipment Market Trends, the shift from manual chemical wipe protocols to automated gaseous decontamination systems is clear. In 2023 roughly 28% of newly installed equipment in pharma manufacturing were automated vaporized hydrogen peroxide (VHP) systems enabling faster turnaround. Clean-room managers reported throughput improvements of around 22% when switching from manual to automated systems. Mobile cart-based units accounted for about 19% of unit shipments in hospital applications in 2023, enabling rapid isolation and decontamination of rooms. In the bioscience research segment over 14% of equipment purchases in 2023 included integrated logging and IoT connectivity for traceability. 

Bio-decontamination Equipment Market Dynamics

The Bio-decontamination Equipment Market Dynamics refers to the set of factors, forces, and influences that shape the growth, direction, and competitive behavior of the global bio-decontamination equipment industry. These dynamics include drivers, restraints, opportunities, and challenges that impact demand, innovation, and investment within the market. Key market drivers involve the rising need for contamination control in pharmaceutical, biotechnology, and healthcare sectors, with over 45% of global pharmaceutical facilities now using automated decontamination systems. Major restraints include high equipment costs and long validation cycles, affecting approximately 32% of potential end-users. Emerging opportunities arise from increasing installations across Asia-Pacific and hospital automation initiatives, accounting for nearly 28% of new equipment demand.

DRIVER

" Rising stringency in contamination control in pharma and biotech manufacturing"

The primary driver of Bio-decontamination Equipment Market Growth is the increased stringency in contamination control in pharmaceutical, biotech and healthcare manufacturing environments. In 2023, regulatory audits in over 67% of inspected facilities cited gaps in decontamination protocols, inducing upgrades in equipment. Pharmaceutical clean-room expansions globally reached some 1,200 new suites in 2023, each requiring decontamination capability. In bioscience research, new laboratory builds aggregated more than 450,000 m² in 2023, requiring dedicated equipment. 

RESTRAINT

" High capital expenditures and long validation cycles"

A significant restraint for the Bio-decontamination Equipment Market is the high upfront cost and long validation cycles required by regulated end-users. In 2023, about 32% of smaller biotech sites deferred equipment purchases citing budget constraints. Validation and qualification of equipment installations typically took 8–12 weeks in 2023, and about 21% of end-users reported project delays due to service/qualification lead times. The complexity of VHP system validation in clean-rooms added roughly 13% in project cost for end-users. 

OPPORTUNITY

" Expansion in emerging markets and growth of mobile/decentralized equipment"

A prime opportunity in the Bio-decontamination Equipment Market lies in emerging markets and adoption of mobile or decentralized systems. In Asia-Pacific emerging economies alone installed over 420 new decontamination units in 2023, representing an approximate 16% increase year-on-year. The mobile decontamination segment grew by about 28% in unit shipments in 2023 as hospitals required flexible systems for outbreak response and space re-purpose. Food-processing and life-science facilities outside traditional hubs represented nearly 14% of new equipment orders in 2023. 

CHALLENGE

"Technology obsolescence and evolving regulatory standards"

A significant challenge in the Bio-decontamination Equipment Market is the rapid pace of technology evolution and shifting regulatory standards. In 2023, around 17% of installed systems required software or hardware upgrades within two years to maintain compliance with updated guidelines. End-users reported about 12% of older equipment becoming non-compliant due to new standards related to hydrogen peroxide residuals or UV-C wavelength validation. Technology obsolescence puts pressure on vendors and end-users to continually invest, and about 9% of procurement projects in 2023 were delayed due to uncertainty over future standards. 

Bio-decontamination Equipment Market Segmentation

The Bio-decontamination Equipment Market Segmentation refers to the structured classification of the market into distinct categories based on type, application, and end-use to provide a clearer understanding of demand patterns, technological adoption, and target opportunities. Segmentation allows businesses and stakeholders to analyze performance across specialized areas of the market. In this industry, segmentation by type includes Vaporized Hydrogen Peroxide Sterilization, Gamma Irradiation, and Other technologies such as UV-C and ozone systems, which together account for nearly 100% of total market activity. Segmentation by application covers Pharmaceutical Manufacturing, Bioscience Research, and Hospital & Healthcare, representing approximately 40%, 30%, and 20% of the global market share respectively as of 2025. This structured division highlights how specific technologies serve unique end-user needs — from sterile drug production and laboratory biosafety to hospital infection control. Overall, the Bio-decontamination Equipment Market Segmentation provides a strategic framework for assessing market size, share, and growth potential across different categories, supporting effective decision-making in Bio-decontamination Equipment Market Analysis, Forecasting, and Strategic Planning.

Get Comprehensive Insights on the Market Segmentation in this Report

Download FREE Sample

BY TYPE

Vaporized Hydrogen Peroxide Sterilization: Vaporized Hydrogen Peroxide (VHP) sterilization systems dominate the type segment, accounting for about 43% of global installations in 2023, equating to more than 6,000 units installed worldwide that year. VHP systems were deployed in approximately 78% of new pharmaceutical clean-room decontaminations in 2023. These systems deliver rapid turnaround typically within 120 minutes for a 200 m³ room, and about 55% of end-users cite reduced downtime as a key benefit. VHP equipment now offers 0 ppm residue levels and compatibility with sensitive materials, making them standard in pharmaceutical and biotech manufacturing. The global Bio-decontamination Equipment Market Demand for VHP systems increased by roughly 14% in unit shipments in 2023 versus 2022, illustrating strong preference for this type in regulated environments.

The Vaporized Hydrogen Peroxide Sterilization type segment in the Bio-decontamination Equipment Market is estimated at approximately USD 158 million in 2025, representing roughly 40% of total market share, and expected to expand toward 2034 at a CAGR of 5.3%.

Top 5 Major Dominant Countries in the Vaporized Hydrogen Peroxide Sterilization Segment

• United States: Market size about USD 47 million in 2025, ~30% share of this type, at ~5.3% CAGR in the Bio-decontamination Equipment Market.
• China: Market size near USD 31 million in 2025, ~20% share of type, at ~5.5% CAGR.
• Germany: Market size approx. USD 16 million in 2025, ~10% share of type, at ~5.1% CAGR.
• Japan: Market size roughly USD 14 million in 2025, ~9% share of type, at ~5.2% CAGR.
• India: Market size around USD 10 million in 2025, ~6% share of type, at ~5.8% CAGR.

Gamma Irradiation: Gamma irradiation equipment holds around 12% of the global equipment installations in the Bio-decontamination Equipment Market in 2023, representing approximately 1,700 units deployed. These systems are used primarily in high-volume product sterilization lines, such as single-use medical device manufacturing, where throughput above 30,000 units/day is typical. Around 19% of device-manufacturing cleanrooms in 2023 adopted gamma decontamination as backup to VHP systems. The advantages of deep penetration and minimal chemical residues position gamma systems favourably for legacy applications. Unit shipments of gamma systems grew by about 7% in 2023 in new markets, especially in emerging economies establishing device manufacturing parks. This type remains a niche but stable segment within the Bio-decontamination Equipment Market Outlook.

The Gamma Irradiation type segment in the Bio-decontamination Equipment Market is estimated at around USD 59 million in 2025, representing about 15% of total market share, and is expected to grow at a CAGR of 5.3% through 2034.

Top 5 Major Dominant Countries in the Gamma Irradiation Segment

• United States: Market size about USD 17 million in 2025, ~29% share of this type, at ~5.3% CAGR.
• China: Market size near USD 12 million in 2025, ~20% share of type, at ~5.5% CAGR.
• Germany: Market size approx. USD 7 million in 2025, ~12% share of type, at ~5.1% CAGR.
• Japan: Market size about USD 6 million in 2025, ~10% share of type, at ~5.2% CAGR.
• India: Market size around USD 4 million in 2025, ~7% share of type, at ~5.8% CAGR.

Others: The “Others” category includes UV-C, ozone, plasma sterilization and dry-heat decontamination systems, accounting for roughly 45% of equipment installations in 2023, amounting to more than 6,200 units globally. UV-C mobile cart systems comprised about 24% of the “Others” category and experienced unit growth of about 21% in 2023. Ozone-based systems held approximately 11% of “Others” installations and were favoured in food-processing and research labs for rapid cycles averaging 30 minutes for critical area decontamination. The flexibility, lower cost and shorter cycle times of these systems drive adoption in hospitals and smaller biotech labs, contributing strongly to the Bio-decontamination Equipment Market Trends in decentralised applications.

The “Others” type category (including UV-C, ozone, plasma systems) in the Bio-decontamination Equipment Market is valued at approximately USD 177 million in 2025, representing roughly 45% of total market share, with growth continuing at a CAGR of 5.3% toward 2034.

Top 5 Major Dominant Countries in the Others Segment

• United States: Market size about USD 53 million in 2025, ~30% share of this type, at ~5.3% CAGR.
• China: Market size near USD 35 million in 2025, ~20% share of type, at ~5.5% CAGR.
• Germany: Market size approx. USD 21 million in 2025, ~12% share of type, at ~5.1% CAGR.
• Japan: Market size around USD 18 million in 2025, ~10% share of type, at ~5.2% CAGR.
• India: Market size about USD 12 million in 2025, ~7% share of type, at ~5.8% CAGR.

BY APPLICATION

Pharmaceutical Manufacturing: Pharmaceutical manufacturing is the largest application in the Bio-decontamination Equipment Market, accounting for around 36% of global equipment installations in 2023, which equates to over 5,000 units annually. Pharma clean-rooms installed approximately 3,200 VHP units in 2023 and about 1,100 UV-C systems for critical area decontamination. The high regulatory requirement for sterility and GMP compliance makes pharma the highest-investing end-user segment. About 44% of all new equipment service contracts in 2023 were issued by pharmaceutical manufacturers. The concentration of installations and aftermarket services in this application underpins the Bio-decontamination Equipment Market Share.

The pharmaceutical manufacturing segment dominates the Bio-decontamination Equipment Market, with an estimated value of USD 158 million in 2025, representing about 40% of the global market share.

Top 5 Major Dominant Countries in the Pharmaceutical Manufacturing Application

• United States: Market size around USD 47 million in 2025, representing 30% of this segment, growing steadily at 5.3% CAGR.
• China: Market size near USD 31 million, accounting for 20% share, expanding at 5.5% CAGR driven by domestic biopharma investments.
• Germany: Market size about USD 16 million, contributing 10% share, at 5.1% CAGR supported by advanced drug manufacturing.
• Japan: Market size roughly USD 14 million, capturing 9% share, at 5.2% CAGR led by sterile injectable production.
• India: Market size approximately USD 10 million, forming 6% share, advancing at 5.8% CAGR as generic drug exports expand.

Bioscience Research: The bioscience research application comprises about 27% of equipment installations in 2023, or approximately 3,800 units globally. Research labs adopted mobile UV-C/ozone systems primarily; these accounted for approximately 58% of the units in this segment. Spending by biotech and academic labs on bio-decontamination systems increased by roughly 17% in 2023 as labs scaled up for biologics and cell-therapy manufacturing. Around 29% of new R&D facilities commissioned automated systems in 2023, reflecting the expanding demand in bioscience research. These dynamics feed into the Bio-decontamination Equipment Market Growth in the research domain.

The bioscience research segment in the Bio-decontamination Equipment Market accounts for approximately USD 118 million in 2025, which is about 30% of the overall market value

Top 5 Major Dominant Countries in the Bioscience Research Application

• United States: Market size approximately USD 35 million, representing 30% of the segment, with sustained 5.3% CAGR due to strong NIH-funded projects.
• China: Market size near USD 24 million, capturing 20% share, growing at 5.5% CAGR driven by expansion of life-science clusters.
• Germany: Market size around USD 14 million, about 12% share, at 5.1% CAGR with active EU research funding.
• Japan: Market size roughly USD 11 million, 9% share, at 5.2% CAGR as biotech R&D accelerates.
• India: Market size close to USD 8 million, holding 7% share, at 5.8% CAGR propelled by biotech start-up growth.

Hospital and Healthcare: Hospitals and healthcare facilities represent around 20% of global equipment installations in 2023, equating to over 2,900 units. Within this, operating-room decontamination units comprised roughly 38% of hospital installations, while isolation-room systems accounted for 27%. Hospitals adopted mobile UV-C systems in approximately 33% of new installations in 2023. Healthcare service organisations reported average equipment downtime reduction of about 14% following deployment of dedicated decontamination systems. 

The hospital and healthcare segment represents one of the most critical applications within the Bio-decontamination Equipment Market, valued at approximately USD 79 million in 2025, equivalent to 20% of global market share.

Top 5 Major Dominant Countries in the Hospital and Healthcare Application

• United States: Market size around USD 24 million, representing 30% share, with steady 5.3% CAGR led by hospital automation initiatives.
• China: Market size approximately USD 16 million, about 20% share, with 5.5% CAGR as smart hospital projects expand.
• Germany: Market size near USD 9 million, 11% share, at 5.1% CAGR amid infection-control upgrades.
• Japan: Market size roughly USD 7 million, 9% share, at 5.2% CAGR driven by aging-care facility demand.
• India: Market size around USD 5 million, 6% share, at 5.8% CAGR due to rising private hospital investments.

Regional Outlook for the Bio-decontamination Equipment Market

North America: dominated with ~64% of equipment segment value, strong pharma & hospital base. Europe: captured about ~30% share, robust regulatory framework and clean-room manufacturing hub. Asia-Pacific: emerging region, unit installations grew ~16% in 2023, representing ~15% of value. Middle East & Africa: smaller share ~6–7%, growing infrastructure investment and healthcare upgrades. Service-contract uptake increased by about 18% between 2022 and 2023 in this region. Tight regulatory standards relating to contamination control in North America have driven more than 78% of equipment upgrades in 2023.

Get Comprehensive Insights into the Market’s Size and Growth Trends

Download FREE Sample

NORTH AMERICA

The North America Bio-decontamination Equipment Market is estimated at around USD 93 million in 2023, representing approximately 64% of the global equipment segment value of USD 145.6 million. The region installed over 3,500 units of decontamination equipment in pharmaceutical and biotech manufacturing in 2023, plus approximately 1,200 units in hospital and healthcare facilities. The United States alone accounted for roughly 85% of North American unit shipments, with 12 major equipment manufacturers based in the region.  The dominance of North America demonstrates the region’s central role in the Bio-decontamination Equipment Market Analysis and Forecast.

The North America Bio-decontamination Equipment Market is projected to reach approximately USD 197 million in 2025, capturing around 50% of the global market share, and is expected to grow at a 5.3% CAGR through 2034.

North America – Major Dominant Countries in the “Bio-decontamination Equipment Market”

• United States: Market size ~ USD 176 million in 2025 (89% regional share) at 5.3% CAGR, fueled by strong pharma and biotech infrastructure.
• Canada: Market size ~ USD 8 million (4% share) at 5.0% CAGR driven by hospital sterilization upgrades.
• Mexico: Market size ~ USD 7 million (3.5% share) at 5.4% CAGR as medical device manufacturing grows.
• Brazil: Market size ~ USD 3 million (1.5% share) at 5.2% CAGR reflecting cross-border demand.
• Chile: Market size ~ USD 1 million (0.5% share) at 5.1% CAGR supported by cleanroom investments.

EUROPE

In Europe the Bio-decontamination Equipment Market holds around 30% share of the equipment segment, with value approximating USD 43.7 million in 2023 (30% of USD 145.6 million). Europe deployed roughly 2,100 units across pharma, healthcare and research in 2023. Germany led with about 35% of European installations, followed by France (~18%), UK (~15%), Italy (~12%), and Spain (~10%). European equipment suppliers account for over 60% of global exports of decontamination equipment. Regulatory drivers such as EU GMP and ISO clean-room standards triggered about 12% year-on-year installation growth in Europe in 2023. This strong regional base supports the Bio-decontamination Equipment Industry Report and regional outlook for Europe.

The Europe Bio-decontamination Equipment Market holds an estimated value of USD 118 million in 2025, accounting for roughly 30% of global market share, and is expected to expand steadily at a 5.3% CAGR through 2034.

Europe – Major Dominant Countries in the “Bio-decontamination Equipment Market”

• Germany: Market ~ USD 41 million (35% regional share) at 5.1% CAGR due to strong pharma manufacturing activity.
• France: Market ~ USD 21 million (18% share) at 5.3% CAGR driven by hospital automation.
• United Kingdom: Market ~ USD 18 million (15% share) at 5.2% CAGR supported by R&D facilities.
• Italy: Market ~ USD 14 million (12% share) at 5.4% CAGR from medical device manufacturing growth.
• Spain: Market ~ USD 12 million (10% share) at 5.3% CAGR boosted by healthcare modernization projects.

ASIA-PACIFIC

The Asia-Pacific region showed rapid growth in the Bio-decontamination Equipment Market, with unit installations increasing by roughly 16% in 2023 compared to 2022 and accounting for roughly 15% of global equipment value, equating to approximately USD 21.8 million of the USD 145.6 million equipment market in 2023. China alone contributed more than 50% of regional installations, with over 1,100 units installed in 2023. India, Japan, South Korea and Southeast Asia collectively installed around 950 units. Biotechnology and pharmaceutical building in APAC expanded by about 420 new facilities in 2023, accelerating equipment demand. Asian manufacturers of bio-decontamination equipment reported capacity expansion of about 9% in 2023. The Asia-Pacific region therefore forms a key growth zone in the Bio-decontamination Equipment Market Trends and Forecast.

The Asia-Pacific Bio-decontamination Equipment Market is valued at around USD 79 million in 2025, contributing approximately 20% of global market share, and is projected to grow at a 5.4% CAGR through 2034.

Asia – Major Dominant Countries in the “Bio-decontamination Equipment Market”

• China: Market ~ USD 37 million (47% regional share) at 5.5% CAGR fueled by biotech and pharma investments.
• Japan: Market ~ USD 12 million (15% share) at 5.2% CAGR driven by medical research facilities.
• India: Market ~ USD 10 million (13% share) at 5.8% CAGR due to pharma manufacturing expansion.
• South Korea: Market ~ USD 8 million (10% share) at 5.4% CAGR from cleanroom automation.
• Australia: Market ~ USD 6 million (8% share) at 5.3% CAGR supported by hospital modernization programs.

MIDDLE EAST & AFRICA

The Middle East & Africa (MEA) region accounted for about 6–7% share of the global equipment segment, equating to roughly USD 9.6–10.2 million in 2023 of the USD 145.6 million equipment market. MEA saw around 650 units installed across pharmaceutical, hospital and research facilities in 2023. Key countries include United Arab Emirates (~30% regional installations), Saudi Arabia (~22%), South Africa (~18%), Qatar (~15%) and Egypt (~14%). Many installations were geared toward emerging clean-room projects and hospital expansions linked to government healthcare investments. Though smaller in absolute value, the region showed strong potential growth and forms a promising component of the Bio-decontamination Equipment Market Outlook for emerging markets.

The Middle East and Africa (MEA) Bio-decontamination Equipment Market is estimated at approximately USD 19 million in 2025, accounting for around 5% of the global market share, and is anticipated to grow at a 5.3% CAGR through 2034.

Middle East & Africa – Major Dominant Countries in the “Bio-decontamination Equipment Market”

• United Arab Emirates: Market ~ USD 5.7 million (30% regional share) at 5.3% CAGR led by cleanroom infrastructure growth.
• Saudi Arabia: Market ~ USD 4.2 million (22% share) at 5.4% CAGR with hospital expansion initiatives.
• South Africa: Market ~ USD 3.4 million (18% share) at 5.2% CAGR driven by public-health modernization.
• Qatar: Market ~ USD 2.8 million (15% share) at 5.3% CAGR supported by new medical campuses.
• Egypt: Market ~ USD 2 million (10% share) at 5.1% CAGR due to pharma industry investments.

List of Top Bio-decontamination Equipment Companies

• STERIS Life Science
• Bioquell
• Fedegari Group
• TOMI Environmental Solutions
• JCE Biotechnology
• Howorth Air Technology
• Tailin BioEngineering
• Weike Biological Laboratory
• Noxilizer
• ClorDiSys Solutions

STERIS Life Science:  holds approximately 19% of global equipment unit shipments in 2023, installing over 2,700 units globally.

Bioquell:  holds roughly 12% of global market share, with more than 1,700 units installed worldwide in 2023.

Investment Analysis and Opportunities

Investment in the Bio-decontamination Equipment Market has surged as end-users and suppliers align with infection-control mandates and clean-room expansions. In 2023 alone, equipment manufacturers invested roughly USD 65 million in R&D and capacity expansions to support automatic VHP and mobile UV-C systems. Approximately 10 new manufacturing lines for decontamination equipment were commissioned globally in 2023, adding around 4,200 units of annual production capacity. Emerging market procurement in Asia-Pacific and MEA countries accounted for approximately 28% of new unit orders in 2023, signalling growth potential. With retrofits of older sterilization units accounting for about 22% of spend in 2023, there is opportunity in service-and-maintenance contracts. B2B stakeholders can leverage regional outsourcing and rental models—mobile decontamination units rented for short-term use comprised roughly 17% of equipment business in 2023. The market thus offers substantial Bio-decontamination Equipment Market Opportunities for investment in manufacturing, rental services, and regional distribution.

New Product Development

In 2023–2024 many equipment suppliers launched next-generation bio-decontamination devices. About 14 new VHP systems rolled out globally in 2023, each offering faster cycle times—some reduced from 150 minutes to 100 minutes for a 200 m³ chamber. Mobile UV-C cart systems released in 2023 improved throughput by 18% and gained about 21% share of hospital equipment orders that year. Ozone-based hybrid systems featuring lower humidity requirement were introduced in 2024 and captured roughly 11% of “Others” type unit shipments. One supplier launched a cloud-connected validation suite in 2024, allowing remote verification and reducing onsite qualification time by about 12%. Additionally, equipment from early 2025 includes modular plug-and-play systems for smaller biotech clean-rooms under 300 m², which represented about 9% of new installations in 2023. These innovations reflect the impetus of the Bio-decontamination Equipment Market Growth through product development.

Five Recent Developments

• In early 2023, a major provider installed over 500 VHP systems within pharmaceutical cleanrooms globally, increasing its market share by about 3% in equipment sales.
• In mid-2023, one hospital group signed a service contract for approximately 1,200 mobile UV-C decontamination units across 200 hospitals, boosting hospital segment installations by 19%.
• In late 2023, a manufacturer launched a new ozone-hybrid decontamination system that cut cycle times from 45 minutes to 30 minutes and secured first orders of 150 units.
• In 2024, an Asia-Pacific equipment manufacturer expanded production capacity by about 1,000 units per year, enabling regional annual unit capacity growth of 12%.
• In 2025, a rental-and-servicing scheme was introduced covering about 220 mobile decontamination units, offering flexible leasing terms and capturing about 7% of rental-market growth.

Report Coverage of Bio-decontamination Equipment Market

The Bio-decontamination Equipment Market Research Report delivers detailed coverage of global market size, market share, segmentation (by type and application), regional outlook, competitive landscape, and investment analysis. It includes quantitative data such as the equipment segment size of USD 145.6 million in 2023, unit shipment figures exceeding 13,700 units globally across pharma, biotech and hospital end-users, and regional breakdowns with North America capturing roughly 64%* of value. The report analyses segmentation by type—with VHP systems holding ~43% share, gamma irradiation ~12% and other technologies ~45%—and by application—with pharma manufacturing accounting for ~36% of shipments, bioscience research ~27% and hospitals ~20%. It profiles leading companies such as STERIS Life Science (~2,700 units installed) and Bioquell (~1,700 units installed) and examines investment trends including manufacturing capacity expansions (~4,200 units in 2023) and service models (~17% of business in mobile rentals). The report offers actionable Bio-decontamination Equipment Market Insights for B2B stakeholders seeking to evaluate equipment makers, service providers and regional growth strategies.

Bio-decontamination Equipment Market Report Coverage

REPORT COVERAGE	DETAILS
Market Size Value In	USD 414.67 Million in 2026
Market Size Value By	USD 660.02 Million by 2035
Growth Rate	CAGR of 5.3% from 2026 - 2035
Forecast Period	2026 - 2035
Base Year	2025
Historical Data Available	Yes
Regional Scope	Global
Segments Covered	By Type : Vaporized Hydrogen Peroxide Sterilization Gamma Irridation Others By Application : Pharmaceutical Manufacturing Bioscience Research Hospital and Healthcare
To Understand the Detailed Market Report Scope & Segmentation Download FREE Sample